USD 526.47
(-3.43%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 89.8 Million USD | -4.26% |
2022 | 93.8 Million USD | 7.82% |
2021 | 87 Million USD | 8.89% |
2020 | 79.9 Million USD | 4.58% |
2019 | 76.4 Million USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | -100.0% |
2004 | 609 Thousand USD | -64.7% |
2003 | 1.72 Million USD | -48.49% |
2002 | 3.34 Million USD | 39.43% |
2001 | 2.4 Million USD | -38.09% |
2000 | 3.88 Million USD | -6.26% |
1999 | 4.13 Million USD | 69.77% |
1998 | 2.43 Million USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | - USD | 0.0% |
2024 Q1 | - USD | -100.0% |
2024 Q3 | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2023 Q4 | 89.8 Million USD | 0.0% |
2023 FY | 89.8 Million USD | -4.26% |
2023 Q1 | - USD | -100.0% |
2023 Q2 | - USD | 0.0% |
2022 FY | 93.8 Million USD | 7.82% |
2022 Q3 | - USD | 0.0% |
2022 Q1 | - USD | -100.0% |
2022 Q4 | 93.8 Million USD | 0.0% |
2022 Q2 | - USD | 0.0% |
2021 Q1 | - USD | -100.0% |
2021 FY | 87 Million USD | 8.89% |
2021 Q2 | - USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2021 Q4 | 87 Million USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 Q4 | 58 Million USD | -78.96% |
2020 Q3 | 275.7 Million USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 FY | 79.9 Million USD | 4.58% |
2019 Q4 | - USD | -100.0% |
2019 Q3 | 72.2 Million USD | 3.74% |
2019 FY | 76.4 Million USD | 0.0% |
2019 Q1 | 71.3 Million USD | 0.0% |
2019 Q2 | 69.6 Million USD | -2.38% |
2018 Q4 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2007 Q1 | 1.4 Million USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 Q2 | - USD | -100.0% |
2006 Q2 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 Q1 | - USD | -100.0% |
2005 Q3 | 35 Thousand USD | -79.53% |
2005 Q2 | 171 Thousand USD | -50.72% |
2005 Q1 | 347 Thousand USD | -43.02% |
2005 FY | - USD | -100.0% |
2005 Q4 | 1 Million USD | 2757.14% |
2004 Q3 | 865 Thousand USD | -23.72% |
2004 FY | 609 Thousand USD | -64.7% |
2004 Q1 | 1.43 Million USD | -16.93% |
2004 Q4 | 609 Thousand USD | -29.6% |
2004 Q2 | 1.13 Million USD | -20.87% |
2003 Q4 | 1.72 Million USD | -18.09% |
2003 Q2 | 2.47 Million USD | -16.39% |
2003 Q1 | 2.96 Million USD | -11.47% |
2003 Q3 | 2.1 Million USD | -15.05% |
2003 FY | 1.72 Million USD | -48.49% |
2002 Q4 | 3.34 Million USD | 5.38% |
2002 Q2 | 1.99 Million USD | -30.53% |
2002 Q1 | 2.86 Million USD | 19.44% |
2002 FY | 3.34 Million USD | 39.43% |
2002 Q3 | 3.17 Million USD | 59.46% |
2001 Q2 | 2.88 Million USD | -18.7% |
2001 FY | 2.4 Million USD | -38.09% |
2001 Q4 | 2.4 Million USD | -16.19% |
2001 Q3 | 2.86 Million USD | -0.56% |
2001 Q1 | 3.54 Million USD | -8.63% |
2000 Q1 | 4.25 Million USD | 0.0% |
2000 Q4 | 3.88 Million USD | 21.94% |
2000 Q3 | 3.18 Million USD | -15.91% |
2000 Q2 | 3.78 Million USD | -11.01% |
2000 FY | 3.88 Million USD | -6.26% |
1999 FY | 4.13 Million USD | 69.77% |
1998 FY | 2.43 Million USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Akoya Biosciences, Inc. | 85.7 Million USD | -4.777% |
AngioDynamics, Inc. | 5.91 Million USD | -1418.431% |
AtriCure, Inc. | 74.49 Million USD | -20.547% |
Avinger, Inc. | 15.39 Million USD | -483.306% |
Azenta, Inc. | 60.43 Million USD | -48.587% |
BioLife Solutions, Inc. | 42.69 Million USD | -110.349% |
The Cooper Companies, Inc. | 2.56 Billion USD | 96.505% |
Daxor Corporation | 755.65 Thousand USD | -11783.667% |
Ekso Bionics Holdings, Inc. | 7.16 Million USD | -1152.79% |
Femasys Inc. | 6.7 Million USD | -1240.122% |
GlucoTrack, Inc. | 196 Thousand USD | -45716.327% |
Harvard Bioscience, Inc. | 42.77 Million USD | -109.946% |
Hologic, Inc. | 2.53 Billion USD | 96.457% |
ICU Medical, Inc. | 1.7 Billion USD | 94.732% |
KORU Medical Systems, Inc. | 4.44 Million USD | -1920.193% |
LeMaitre Vascular, Inc. | 19.09 Million USD | -370.28% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Masimo Corporation | 970 Million USD | 90.742% |
Microbot Medical Inc. | 231 Thousand USD | -38774.459% |
Meihua International Medical Technologies Co., Ltd. | 7.33 Million USD | -1124.913% |
Merit Medical Systems, Inc. | 891.35 Million USD | 89.925% |
Nephros, Inc. | 1.83 Million USD | -4791.068% |
NovoCure Limited | 596.24 Million USD | 84.939% |
NEXGEL, Inc. | 2.79 Million USD | -3109.435% |
NEXGEL, Inc. | 2.79 Million USD | -3109.435% |
Singular Genomics Systems, Inc. | 75.28 Million USD | -19.275% |
OraSure Technologies, Inc. | 13.5 Million USD | -564.988% |
Pro-Dex, Inc. | 13.54 Million USD | -562.877% |
Pulse Biosciences, Inc. | 9.14 Million USD | -882.065% |
Predictive Oncology Inc. | 2.85 Million USD | -3043.362% |
Precision Optics Corporation, Inc. | 3.43 Million USD | -2514.675% |
QuidelOrtho Corporation | 2.61 Billion USD | 96.565% |
Repligen Corporation | 711.8 Million USD | 87.384% |
Sanara MedTech Inc. | 11.79 Million USD | -661.526% |
STAAR Surgical Company | 35.83 Million USD | -150.6% |
Sharps Technology, Inc. | - USD | -Infinity% |
Utah Medical Products, Inc. | 342 Thousand USD | -26157.31% |
DENTSPLY SIRONA Inc. | 2.29 Billion USD | 96.094% |
Jin Medical International Ltd. | 4.11 Million USD | -2083.321% |